CRYO-CELL INTERNATIONAL, INC. Comprehensive Income
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Comprehensive Income of $2.29 million for the 12-month period ending 2019-11-30, per its 10-K filed 2020-02-28.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2020-02-28
- CRYO-CELL INTERNATIONAL, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-11-30 was $844.97K, a 7.55% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-08-31 was $1.12M, a 110.52% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-05-31 was $53.67K, a 90.07% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-02-28 was $275.88K.
- CRYO-CELL INTERNATIONAL, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was $2.29M.
- CRYO-CELL INTERNATIONAL, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$554.71K, a 123.89% decline from fiscal 2017.
- CRYO-CELL INTERNATIONAL, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was $2.32M.
- CRYO-CELL INTERNATIONAL, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$1.46M, a 117.60% decline from fiscal 2015.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2019-11-30 | $844.97K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $1.96M derived: sum of 2 quarters · filed 2020-02-28 | $2.01M derived: sum of 3 quarters · filed 2020-02-28 | $2.29M 10-K · filed 2020-02-28 |
| 2019-08-31 | $1.12M 10-Q · filed 2019-10-15 | $1.17M derived: sum of 2 quarters · filed 2019-10-15 | $1.45M 10-Q · filed 2019-10-15 | $2.23M derived: sum of 4 quarters · filed 2020-02-28 |
| 2019-05-31 | $53.67K 10-Q · filed 2019-07-15 | $329.55K 10-Q · filed 2019-07-15 | $1.12M derived: sum of 3 quarters · filed 2020-02-28 | $1.65M derived: sum of 4 quarters · filed 2020-02-28 |
| 2019-02-28 | $275.88K 10-Q · filed 2019-04-15 | $1.06M derived: sum of 2 quarters · filed 2020-02-28 | $1.59M derived: sum of 3 quarters · filed 2020-02-28 | $2.13M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-11-30 | $785.62K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $1.32M derived: sum of 2 quarters · filed 2020-02-28 | $1.86M derived: sum of 3 quarters · filed 2020-02-28 | -$554.71K 10-K · filed 2020-02-28 |
| 2018-08-31 | $530.24K 10-Q · filed 2019-10-15 | $1.07M derived: sum of 2 quarters · filed 2019-10-15 | -$1.34M 10-Q · filed 2019-10-15 | -$715.33K derived: sum of 4 quarters · filed 2019-10-15 |
| 2018-05-31 | $540.76K 10-Q · filed 2018-07-16 | -$1.87M 10-Q · filed 2019-07-15 | -$1.25M derived: sum of 3 quarters · filed 2019-07-15 | -$559.51K derived: sum of 4 quarters · filed 2019-07-15 |
| 2018-02-28 | -$2.41M 10-Q · filed 2019-04-15 | -$1.79M derived: sum of 2 quarters · filed 2019-04-15 | -$1.10M derived: sum of 3 quarters · filed 2019-04-15 | -$569.63K derived: sum of 4 quarters · filed 2019-04-15 |
| 2017-11-30 | $625.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $1.31M derived: sum of 2 quarters · filed 2019-02-28 | $1.84M derived: sum of 3 quarters · filed 2019-02-28 | $2.32M 10-K · filed 2019-02-28 |
| 2017-08-31 | $686.06K 10-Q · filed 2018-10-15 | $1.22M derived: sum of 2 quarters · filed 2018-10-15 | $1.70M 10-Q · filed 2018-10-15 | $2.48M derived: sum of 4 quarters · filed 2018-10-15 |
| 2017-05-31 | $530.64K 10-Q · filed 2018-07-16 | $1.01M 10-Q · filed 2018-07-16 | $1.80M derived: sum of 3 quarters · filed 2018-07-16 | -$859.80K derived: sum of 4 quarters · filed 2018-07-16 |
| 2017-02-28 | $479.86K 10-Q · filed 2018-04-16 | $1.27M derived: sum of 2 quarters · filed 2018-04-16 | -$1.39M derived: sum of 3 quarters · filed 2018-04-16 | -$759.80K derived: sum of 4 quarters · filed 2018-04-16 |
| 2016-11-30 | $788.18K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$1.87M derived: sum of 2 quarters · filed 2018-02-28 | -$1.24M derived: sum of 3 quarters · filed 2018-02-28 | -$1.46M 10-K · filed 2018-02-28 |
| 2016-08-31 | -$2.66M 10-Q · filed 2017-10-16 | -$2.03M derived: sum of 2 quarters · filed 2017-10-16 | -$2.24M 10-Q · filed 2017-10-16 | -$2.44M derived: sum of 4 quarters · filed 2017-10-16 |
| 2016-05-31 | $630.64K 10-Q · filed 2017-07-07 | $413.98K 10-Q · filed 2017-07-07 | $221.16K derived: sum of 3 quarters · filed 2017-07-07 | $7.97M derived: sum of 4 quarters · filed 2017-07-07 |
| 2016-02-29 | -$216.66K 10-Q · filed 2017-04-13 | -$409.48K derived: sum of 2 quarters · filed 2017-04-13 | $7.34M derived: sum of 3 quarters · filed 2017-04-13 | $7.77M derived: sum of 4 quarters · filed 2017-04-13 |
| 2015-11-30 | -$192.82K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $7.55M derived: sum of 2 quarters · filed 2017-02-28 | $7.99M derived: sum of 3 quarters · filed 2017-02-28 | $8.28M 10-K · filed 2017-02-28 |
| 2015-08-31 | $7.75M 10-Q · filed 2016-10-17 | $8.18M derived: sum of 2 quarters · filed 2016-10-17 | $8.47M 10-Q · filed 2016-10-17 | $8.17M derived: sum of 4 quarters · filed 2016-10-17 |
| 2015-05-31 | $436.31K 10-Q · filed 2016-07-11 | $722.48K 10-Q · filed 2016-07-11 | $426.64K derived: sum of 3 quarters · filed 2016-07-11 | $663.22K derived: sum of 4 quarters · filed 2016-07-11 |
| 2015-02-28 | $286.17K 10-Q · filed 2016-04-14 | -$9.66K derived: sum of 2 quarters · filed 2016-04-14 | $226.91K derived: sum of 3 quarters · filed 2016-04-14 | $442.68K derived: sum of 4 quarters · filed 2016-04-14 |
| 2014-11-30 | -$295.83K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$59.26K derived: sum of 2 quarters · filed 2016-02-29 | $156.51K derived: sum of 3 quarters · filed 2016-02-29 | $553.62K 10-K · filed 2016-02-29 |
| 2014-08-31 | $236.57K 10-Q · filed 2015-10-15 | $452.35K derived: sum of 2 quarters · filed 2015-10-15 | $849.46K 10-Q · filed 2015-10-15 | |
| 2014-05-31 | $215.77K 10-Q · filed 2015-07-15 | $612.88K 10-Q · filed 2015-07-15 | ||
| 2011-11-30 | -$2.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |